Summary of patient records by trust
| Demographics | DGH1 (n=46) | T1 (n=139) | DGH2 (n=47) | Total (N=232) | |
| Patients diagnosed per year, M (SD) | 9.2 (5.63) | 27.8 (7.16) | 9.4 (4.77) | 46.40 (9.24) | |
| Year of diagnosis, n (%) | 2015/2016 | 1 (2.2) | 17 (23.3) | 13 (27.7) | 31 (13.4) |
| 2016/2017 | 8 (17.4) | 32 (23.0) | 8 (17.0) | 48 (20.7) | |
| 2017/2018 | 8 (17.4) | 28 (20.1) | 10 (21.3) | 46 (19.8) | |
| 2018/2019 | 14 (30.4) | 26 (18.7) | 14 (29.8) | 54 (23.3) | |
| 2019/2020 | 15 (32.6) | 36 (25.9) | 2 (4.3) | 53 (22.8) | |
| Mortality, n (%) | Alive | 15 (32.6) | 37 (26.6) | 6 (12.8) | 58 (25.0) |
| Deceased | 31 (67.4) | 102 (73.4) | 41 (87.2) | 174 (75.0) | |
| Age at diagnosis (years), M (SD) | 75.80 (7.75) | 76.65 (8.84) | 73.02 (11.50) | 75.75 (9.31) | |
| Treatment, n (%) | Chemotherapy | 14 (30.4) | 54 (38.8) | 8 (17) | 76 (32.8) |
| Radiotherapy | 3 (6.5) | 27 (19.4) | 3 (6.4) | 33 (14.2) | |
| Surgery | 8 (17.4) | 27 (19.4) | 2 (4.3) | 37 (15.9) | |
| Trial | 4 (8.7) | 18 (12.9) | 2 (4.3) | 24 (10.3) | |
| Immunotherapy | 0 | 12 (8.6) | 0 | 12 (5.2) | |
| Best supportive care only* | 24 (52.2) | 50 (36.0) | 29 (61.7) | 103 (44.4) | |
| No treatment | 1 (2.2) | 5 (3.6) | 5 (10.6) | 11 (4.7) | |
| Clinical care team(s), n (%) | Respiratory only | 0 | 24 (17.3) | 4 (8.5) | 28 (12.1) |
| Oncology only | 12 (26.1) | 5 (3.6) | 1 (2.1) | 18 (7.8) | |
| Palliative only | 29 (63.0) | 5 (3.6) | 34 (72.3) | 68 (29.3) | |
| Shared care | 4 (8.7) | 97 (69.8) | 4 (8.5) | 105 (45.3) | |
| Other or no care team recorded | 1 (2.2) | 8 (5.8) | 4 (8.5) | 13 (5.6) | |
| Survival time (months), M (SD) | 13.19 (2.26) | 18.64 (1.86) | 12.67 (2.08) | 16.60 (1.36) | |
*Includes pleural management.
DGH, district general hospital; TC1, tertiary centre.